MYOVANT

Pharmaceuticals for the use in oncology, endocrinology, and in treatment of hormone related diseases and conditions and in treatment of women's health issues, namely, infertility, uterine fibroids and symptoms thereof, endometriosis and symptoms thereof, and symptoms of menopause